Mar. 4, 2026
Oculis Stock Price Expected to Rise, Analyst Says
Needham & Company LLC lifts price target on Oculis shares
Mar. 4, 2026
Monte Rosa Therapeutics Sees Surge in Short Interest
Biotech firm's stock sees 21.7% increase in short positions in February
Mar. 4, 2026
Citigroup Boosts Stake in Akebia Therapeutics by Over 1,300%
The financial firm now owns nearly 2 million shares in the biopharmaceutical company.
Mar. 3, 2026
Insider Sells $90,298 in Vera Therapeutics Stock
Robert Brenner, a Vera Therapeutics insider, sold over 2,000 shares of the biotech company's stock.
Mar. 3, 2026
Short Interest in EverQuote Rises 59.7% in February
Approximately 18.2% of the company's shares are currently sold short
Mar. 3, 2026
Zenas BioPharma Receives 'Moderate Buy' Rating from Analysts
Eight analysts cover the biotech company, with six issuing buy recommendations and one sell rating.
Mar. 3, 2026
HC Wainwright Estimates EWTX FY2026 Earnings
Analysts project Edgewise Therapeutics' earnings per share for fiscal year 2026 and beyond.
Mar. 3, 2026
Neumora Therapeutics to Report Q4 2025 Earnings on Monday
The clinical-stage biopharmaceutical company focused on central nervous system disorders will release its latest quarterly results.
Mar. 3, 2026
Monashee Investment Management Boosts Stake in Compass Therapeutics
Hedge fund increases position in biotech company by over 650%
Mar. 3, 2026
TD Asset Management Boosts Biogen Holdings
Institutional investor increases stake in biotech company by 12.7% in Q3
Mar. 2, 2026
GSA Capital Partners LLP Cuts Stake in Neumora Therapeutics
Hedge fund reduces position in biotech company by 88% in Q3
Mar. 2, 2026
Neumora Therapeutics Shares Plummet on Monday
Biotech stock drops over 20% as investors react to latest developments
Mar. 2, 2026
Brokerages Set Biogen Inc. (NASDAQ:BIIB) Price Target at $205.04
Analysts maintain 'Hold' rating on the biotech company's stock.
Mar. 2, 2026
BTIG Cuts Aardvark Therapeutics Price Target to $9
Biotech firm's stock downgraded amid concerns over future prospects
Feb. 28, 2026
Piper Sandler Cuts Cardiff Oncology Price Target to $6.00
The firm maintains an overweight rating on the stock despite lowering its price target.
Feb. 28, 2026
Wall Street Zen Upgrades EverQuote to Strong-Buy
Analysts cite strong financial performance and growth potential for the online insurance marketplace.
Feb. 28, 2026
Akebia Therapeutics Downgraded to 'Strong Sell' by Zacks Research
Analysts cite concerns over the company's financial performance and outlook
Feb. 28, 2026
Banco Santander Boosts Stake in Moderna
Institutional investor increases ownership in COVID-19 vaccine maker
Feb. 28, 2026
Citigroup Reduces Stake in Pegasystems
Institutional investor sells 36,772 shares of software company
Feb. 28, 2026
Wall Street Zen Upgrades Sarepta Therapeutics Stock Rating
Analysts raise stock from "sell" to "hold" rating for the biotech company.
